The BURAN Study of Buparlisib in Patients With Recurrent or Metastatic HNSCC
Clinical trial NCT04338399 · COMPLETED
Trial details
- NCT number
- NCT04338399
- Sponsor
- Adlai Nortye Biopharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-12
- Primary completion
- 2025-11-02
- Enrollment
- 487
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.